Skip to main content
. Author manuscript; available in PMC: 2019 Oct 1.
Published in final edited form as: Spine J. 2018 Feb 23;18(10):1741–1754. doi: 10.1016/j.spinee.2018.02.019

Table 1. Baseline characteristics.

Oregon Minnesota SMT 0 (n = 64) SMT 6 (n=65) SMT 12 (n = 64) SMT 18 (n = 63) All (n=256)
Sociodemographic information
 Age (y) 37 (12) 45 (12) 40 (12) 40 (12) 43 (13) 42 (14) 41 (13)
 Female 95 (74.2%) 87 (68.0%) 48 (75.0%) 45 (69.2%) 45 (70.3%) 44 (69.8%) 182 (71.1%)
 White non-Hispanic 104 (81.2%) 110 (85.9%) 53 (82.8%) 58 (89.2%) 51 (79.7%) 52 (82.5%) 214 (83.6%)
 Married or living together 66 (51.6%) 92 (71.9%) 39 (60.9%) 34 (52.3%) 42 (65.6%) 43 (68.3%) 158 (61.7%)
 College graduate 86 (67.2%) 85 (66.4%) 36 (56.2%) 46 (70.8%) 41 (64.1%) 48 (76.2%) 171 (66.8%)
 Household income < $40,000 62 (48.4%) 24 (19.2%) 20 (31.7%) 30 (46.9%) 18 (28.6%) 18 (28.6%) 86 (34.0%)
 Smoker 11 (8.6%) 10 (7.8%) 6 (9.4%) 5 (7.7%) 5 (7.8%) 5 (7.9%) 21 (8.2%)
Confidence in treatment success (expectations)
 Spinal manipulation (1–7 scale)* 5.1 (1.1) 5.0 (1.0) 5.0 (1.1) 5.0 (1.0) 5.2 (1.2) 5.1 (1.0) 5.1 (1.1)
 Light massage ((1–7 scale)* 4.8 (1.4) 4.8 (1.2) 4.9 (1.2) 4.7 (1.3) 4.9 (1.4) 4.8 (1.4) 4.8 (1.3)
 Difference (manipulation – light massage) 0.3 (1.6) 0.2 (1.2) 0.1 (1.5) 0.3 (1.4) 0.4 (1.5) 0.3 (1.3) 0.3 (1.4)
Physical activity (Minutes / day) 86 (106) 85 (120) 95 (130) 69 (85) 69 (85) 99 (143) 85 (113)
 (Days / wk) 5.4 (1.5) 5.2 (1.7) 5.3 (1.5) 5.3 (1.6) 5.4 (1.6) 5.1 (1.7) 5.3 (1.6)
Previous care for CGH
 Chiropractic 67 (52.3%) 59 (46.1%) 29 (45.3%) 28 (43.1%) 34 (53.1%) 35 (55.6%) 126 (49.2%)
 Massage 60 (46.9%) 46 (35.9%) 27 (42.2%) 23 (35.4%) 31 (48.4%) 25 (39.7%) 106 (41.4%)
 Chiropractic or massage 77 (60.2%) 63 (49.2%) 34 (53.1%) 30 (46.2%) 40 (62.5%) 36 (57.1%) 140 (54.7%)
Headache and neck complaint
 Days with CGH ( last 4 wk) 15.8 (6.7) 15.3 (6.6) 15.1 (6.3) 15.2 (7.2) 16.2 (6.9) 15.8 (6.1) 15.6 (6.6)
 Average CGH pain intensity (0–10 scale) 4.5 (1.1) 4.5 (1.1) 4.4 (1.0) 4.4 (1.0) 4.5 (1.1) 4.7 (1.1) 4.5 (1.1)
 CGH Duration (y) 7.9 (8.0) 6.7 (7.9) 5.7 (6.4) 8.1 (9.3) 8.4 (8.5) 6.9 (7.1) 7.3 (7.9)
 CGH-related disability (36–78) 58.7 (4.6) 56.1 (4.9) 58.5 (4.6) 56.0 (5.2) 57.2 (5.1) 57.9 (4.4) 57.4 (4.9)
 Lost work due to CGH
  1/2 day or more 69 (53.9%) 36 (28.1%) 25 (38.5%) 26 (40.6%) 27 (42.9%) 69 (53.9%) 105 (41.0%)
  If yes, days with lost work (last 4 wk) 2.0 (3.7) 1.2 (4.3) 1.4 (3.7) 1.7 (4.6) 1.8 (4.1) 1.4 (3.8) 1.6 (4.1)
 Days with non-CGH headaches (last 4 wk) 2.3 (2.7) 2.3 (3.0) 2.3 (3.1) 2.4 (3.0) 2.3 (2.4) 2.2 (3.1) 2.3 (2.9)
 Days with neck pain (last 4 wk) 18.8 (7.2) 17.9 (7.8) 19.2 (7.6) 18.8 (7.2) 18.2 (8.0) 17.1 (7.3) 18.3 (7.5)
 Average neck pain intensity (0–10 scale) 4.6 (1.5) 4.6 (1.5) 4.5 (1.5) 4.5 (1.4) 4.5 (1.5) 4.8 (1.5) 4.6 (1.5)
Health Status
 Tension Type Headache 30 (23.4%) 23 (18.0%) 14 (21.9%) 13 (20.0%) 13 (20.3%) 13 (20.6%) 53 (20.7%)
 Migraine 31 (24.2%) 25 (19.5%) 14 (21.9%) 15 (23.1%) 14 (21.9%) 13 (20.6%) 56 (21.9%)
 Lower back problems 43 (33.6%) 43 (33.6%) 19 (29.7%) 20 (30.8%) 22 (34.4%) 25 (39.7%) 86 (33.6%)
 Any back problems 70 (54.7%) 70 (54.7%) 37 (57.8%) 32 (49.2%) 35 (54.7%) 36 (57.1%) 140 (54.7%)
 Any comorbidity 90 (70.3%) 87 (68.0%) 45 (70.3%) 39 (60.0%) 49 (76.6%) 44 (69.8%) 177 (69.1%)
 EuroQol “Health State Today” (0–100 VAS) 74.4 (13.7) 76.7 (13.2) 74.9 (13.7) 76.3 (11.3) 76.1 (13.9) 74.8 (15.0) 75.5 (13.5)
Days taking medication for CGH (last 4 wk) 6.3 (4.9) 6.3 (4.6) 5.6 (4.5) 5.9 (4.0) 6.6 (5.4) 7.0 (4.8) 6.3 (4.7)

SMT, spinal manipulative therapy; CGH, cervicogenic headache; VAS, visual analog scale.

Values are mean (standard deviation) or number (percentage).

*

Seven-point Likert scale from extremely doubtful (1) to extremely confidence (7) in treatment success.

Lower scores are more favorable with the exception of the EuroQol VAS.

Any back problems includes upper, middle, and lower back. Comorbidity includes any of the following: diabetes or arthritis, back, lung, cardiovascular, gastrointestinal, urinary, gynecological, or prostate problems.